Drug Shortage Report for ACT SUMATRIPTAN
Report ID | 92684 |
Drug Identification Number | 02257904 |
Brand name | ACT SUMATRIPTAN |
Common or Proper name | SUMATRIPTAN |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SUMATRIPTAN |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 6 U/D |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-08-28 |
Estimated end date | |
Actual end date | 2019-09-30 |
Shortage status | Resolved |
Updated date | 2020-07-10 |
Company comments | Product size has been discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-07-10 | French | Compare |
v3 | 2020-07-10 | English | Compare |
v2 | 2019-08-29 | French | Compare |
v1 | 2019-08-29 | English | Compare |
Showing 1 to 4 of 4